With SARS, Antivirus Arms Race Heats Up
May 28, 2003 | Source: New York Times
The development of antiviral drugs has lagged behind that of antibacterial drugs, but a variety of approaches is currently being applied to developing defensive technologies against viruses.
Editorial comment: “Of all the things we can do for GNR [genetics, nanotechnology, and robotics] defense, developing defensive technologies against viruses is the most important right now,” comments Ray Kurzweil.